Master regulator found for regenerating nerve fibers in live animalsOctober 26, 2009Enzyme could lead to a possible treatment for brain and spinal cord injury Boston, Mass. -- Researchers at Children's Hospital Boston report that an enzyme known as Mst3b, previously identified in their lab, is essential for regenerating damaged axons (nerve fibers) in a live animal model, in both the peripheral and central nervous systems. Their findings, published online by Nature Neuroscience on October 25, suggest Mst3b - or agents that stimulate it - as a possible means of treating stroke, spinal cord damage and traumatic brain injury. Normally, neurons in the central nervous system (the brain and spinal cord) cannot regenerate injured nerve fibers, limiting people's ability to recover from brain or spinal cord injuries. The study, led by Nina Irwin, PhD and Larry Benowitz, PhD, of the Laboratories for Neuroscience Research in Neurosurgery and the F.M. Kirby Neurobiology Center at Children's, builds on previous discoveries in the lab. In 2002, they showed that a naturally occurring small molecule, inosine, stimulates axon regeneration, later showing that it helps restore neurological functions in animal models of injury. In 2006, Benowitz and colleagues reported a previously unknown growth factor, oncomodulin, to have dramatic effects on axon growth. Investigating the mechanisms of action of inosine and oncomodulin, Irwin and Benowitz discovered that both compounds activate Mst3b, an enzyme that appears to be a master regulator of a cell-signaling pathway controlling axon growth. Mst3b, a protein kinase, in turn activates signals that switch on the genes necessary for axons to grow. Working with live rats whose optic nerve was damaged (a common model of central-nervous-system injury), Irwin, Benowitz and colleagues show that in the absence of Mst3b, axons show very little regeneration, even in the presence of factors known to enhance axon growth. In cell cultures, axon growth increased when activated Mst3b was expressed in the neurons. "All the growth factors we've tested - oncomodulin, inosine, brain-derived neurotropic factor, nerve growth factor - act through Mst3b," says Benowitz. "In fact, activating Mst3b by itself is enough to cause growth even if there are no growth factors around. In terms of basic understanding of nerve cells, this is a very exciting finding." Further studies examining how Mst3b exerts this growth-promoting effect may open up new avenues for treating brain and spinal cord injuries, Benowitz says. While this study explains why growth factors work - because they stimulate Mst3b - it's not yet known whether Mst3b is the best stimulator of axon growth from a practical drug-development standpoint, he adds. Irwin is now working on possible gene therapy approaches involving Mst3b. Activating Mst3b may help overcome some natural "brakes" in the cell-signaling system that prevent nerve regeneration under normal conditions. Children's Hospital Boston |
|||||||||||||||||||||
| Related Brain Spinal Cord Current Events and Brain Spinal Cord News Articles Mutation may cause inherited neuropathy Mutations in a protein called dynein, required for the proper functioning of sensory nerve cells, can cause defects in mice that may provide crucial clues leading to better treatments for a human nerve disorder known as peripheral neuropathy, which affects about three percent of all those over age 60. New therapeutic targets for neurodegenerative diseases The focus of work in the Neurosciences Department's Neurobiology Laboratory at the University of the Basque Country's Faculty of Medicine and Odontology is the investigation of the molecular and cellular bases of neurodegenerative illnesses - those that affect the brain and the spinal cord. Zinc plays important role in brain circuitry To the multitude of substances that regulate neuronal signaling in the brain and spinal cord add a new key player: zinc. By engineering a mouse with a mutation affecting a neuronal zinc target, researchers have demonstrated a central role for zinc in modulating signaling among the neurons. New study identifies key gene in development of connections between brain and spinal cord A new study, presented at the American College of Neuropsychopharmacology's (ACNP) Annual Meeting, has identified a specific gene that is necessary for the development of connections between the brain and the spinal cord. New UW study offers strategy for treatment of fatal nervous system disorder Working with mice, University of Wisconsin-Madison researchers have developed the basis for a therapeutic strategy that could provide hope for children afflicted with Krabbe's disease, a fatal nervous system disorder. Spinal cord repair: pilot trials "within sight" When the brain and spinal cord are injured, the damage is permanent, because the tissues cannot repair themselves in the way that bone and skin can. Writing in the June Journal of the Royal Society of Medicine, Dr Geoffrey Raisman describes encouraging results from a new approach to the problem, which he believes will make it possible to plan a pilot trial involving human patients. Dr Raisman led a team at the National Institute for Medical Research which successfully healed the injured spinal cord of an adult rat. They were able to grow a bridge of olfactory nerve cells across the scar tissue, which acted as a guide so the severed nerve fibres could find their way to the right targets in th Researchers Discover New Factor in Nerve Regeneration Researchers in Oxford University's Department of Human Anatomy have identified a factor involved in the regeneration of neurons in the central nervous system. The discovery and use of this factor could provide the basis for a reparative treatment for both brain and spinal cord injuries. Unlike lower vertebrates, mammals have lost the ability to repair damage to the brain and spinal cord. Since peripheral nerves are capable of repair, this is thought to be not so much an intrinsic inability of central nervous system (CNS) tissue to repair itself, but rather an environment in the CNS that is hostile to regeneration. This inhibition of neuronal regeneration is a result of a number of factors in A glimmer of hope in the struggle against neurodegenerative diseases: the virtues of proteins that can save dying neurons Diseases characterized by neurodegeneration affect individuals over 50 years of age and they attack one particular class of neurons in the brain or spinal cord. The research interest of Professor Ann Kato and her team is principally focalized on ALS in which there is a progressive paralysis caused by the destruction of motor neurons which exist in both the brain and spinal cord. These cells are responsible for the movements of the upper and lower limbs and their elimination causes muscular atrophy and finally death. During the last 3 years, the objectives of the experiments of Professor Kato consist in trying to understand why these neurons die and to study the intracellular and molecular pa More Brain Spinal Cord Current Events and Brain Spinal Cord News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||